Article
15 Oct 2026
India's Draft Biotech Patent Guidelines: What U.S. Applicants Should Know Now
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
11 Aug 2026
USPTO Appeals Review Panel Reinstates Double Patenting Rejection in Ex parte Baurin, Limits Reach of Allergan
Article
14 Jul 2026
The $107.5 Million Dosage Gap: Enablement Lessons From Wyeth v. AstraZeneca
Article
13 Jul 2026
The “Skinny Label” Lesson: Hikma Applied To Functional Food And Beverage Brands
Article
19 Jun 2026
Evolving And Modernizing Pharmaceutical IP Portfolio Planning
Article
17 Jun 2026
Lessons Learned: When A Non-Traditional Innovator Defends Genus-Level Biologic Patents
Article
11 May 2026
The Power Of 'About': How One Word Can Make Or Break A Patent Claim
Article
24 Mar 2026
AI Is Rewriting The Rules Of IP Law
Article
20 Feb 2026
Speaking Two Languages: How Life Science Patent Attorneys Bridge The Gap Between Scientists And The Law
Article
15 Jan 2025
Important Update: USPTO Fee Changes Effective January 2025